title: Letter by Kurnik et al regarding article, "antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations".
authors.forename: Yvonne
authors.initials: Y
authors.lastname: Schwammenthal
authors.forename: David
authors.initials: D
authors.lastname: Tanne
authors.forename: Daniel
authors.initials: D
authors.lastname: Kurnik
mesh_terms: D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology*; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D020786:Hemangioma, Cavernous, Central Nervous System / Q000453:epidemiology*; D006801:Humans; D008297:Male
chemical_list: D005343:Fibrinolytic Agents